Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

Week in Review: 4 cardiac arrhythmias associated with COVID-19 |Catheter ablation & AFib | CV health and race

News You Need to Know Today
Week in Review: 4 cardiac arrhythmias associated with COVID-19 |Catheter ablation & AFib | CV health and race
Saturday, June 6, 2020
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

This Week’s News

Top Stories

4 cardiac arrhythmias associated with COVID-19

The association between COVID-19 and cardiac arrhythmias is significant, especially when patients are hit hard by the disease and moved to the ICU. 

READ MORE >
covid.jpg
Share on Twitter Share on Facebook Share on Linkedin

4 cardiac arrhythmias associated with COVID-19

Share on Twitter Share on Facebook Share on Linkedin
covid.jpg
The association between COVID-19 and cardiac arrhythmias is significant, especially when patients are hit hard by the disease and moved to the ICU. 
READ MORE >

Conscious sedation associated with better TAVR outcomes than general anesthesia

The use of conscious sedation during transcatheter aortic valve replacement is associated with better patient outcomes, including a decrease in mortality, than general anesthesia.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Conscious sedation associated with better TAVR outcomes than general anesthesia

Share on Twitter Share on Facebook Share on Linkedin
The use of conscious sedation during transcatheter aortic valve replacement is associated with better patient outcomes, including a decrease in mortality, than general anesthesia.
READ MORE >

What new research tells us about catheter ablation and atrial fibrillation

Treating atrial fibrillation (AF) patients with catheter ablation is associated with a decreased risk of mortality, heart failure admission and stroke, according to new findings published in the Journal of the American Heart Association.

READ MORE >
ECG
Share on Twitter Share on Facebook Share on Linkedin

What new research tells us about catheter ablation and atrial fibrillation

Share on Twitter Share on Facebook Share on Linkedin
ECG
Treating atrial fibrillation (AF) patients with catheter ablation is associated with a decreased risk of mortality, heart failure admission and stroke, according to new findings published in the Journal of the American Heart Association.
READ MORE >

In wake of George Floyd’s death, cardiovascular groups denounce ‘incidents of racism and violence’

The Association of Black Cardiologists, American Heart Association and American College of Cardiology have collaborated on a joint statement that touches on the death of George Floyd and its connection to the cardiovascular health of racial minorities in the United States.   

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

In wake of George Floyd’s death, cardiovascular groups denounce ‘incidents of racism and violence’

Share on Twitter Share on Facebook Share on Linkedin
The Association of Black Cardiologists, American Heart Association and American College of Cardiology have collaborated on a joint statement that touches on the death of George Floyd and its connection to the cardiovascular health of racial minorities in the United States.   
READ MORE >

Welldoc receives additional FDA approval for digital diabetes solution

Welldoc, a Columbia, Maryland-based digital health company, has gained an additional FDA approval for its BlueStar diabetes management solution.

READ MORE >
approved approval
Share on Twitter Share on Facebook Share on Linkedin

Welldoc receives additional FDA approval for digital diabetes solution

Share on Twitter Share on Facebook Share on Linkedin
approved approval
Welldoc, a Columbia, Maryland-based digital health company, has gained an additional FDA approval for its BlueStar diabetes management solution.
READ MORE >

Featured Articles

FFR-guided PCI earns high marks as a treatment option for patients with stable angina pectoris

Fractional flow reserve guidance can help cardiologists make better decisions during percutaneous coronary intervention—can it lead to better outcomes for patients with stable angina pectoris?

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

FFR-guided PCI earns high marks as a treatment option for patients with stable angina pectoris

Share on Twitter Share on Facebook Share on Linkedin
Fractional flow reserve guidance can help cardiologists make better decisions during percutaneous coronary intervention—can it lead to better outcomes for patients with stable angina pectoris?
READ MORE >

FDA approves use of ticagrelor for high-risk CAD patients

Ticagrelor has been approved by the FDA for reducing the risk of a first heart attack or stroke in high-risk coronary artery disease (CAD) patients.

READ MORE >
heart.png
Share on Twitter Share on Facebook Share on Linkedin

FDA approves use of ticagrelor for high-risk CAD patients

Share on Twitter Share on Facebook Share on Linkedin
heart.png
Ticagrelor has been approved by the FDA for reducing the risk of a first heart attack or stroke in high-risk coronary artery disease (CAD) patients.
READ MORE >

FDA recalls multiple lots of extended-release metformin due to contamination

The FDA is pushing for a voluntary recall of certain lots of extended-release metformin after lab tests revealed unacceptable levels of N-nitrosodimethylamine.

READ MORE >
Recall | Product recall
Share on Twitter Share on Facebook Share on Linkedin

FDA recalls multiple lots of extended-release metformin due to contamination

Share on Twitter Share on Facebook Share on Linkedin
Recall | Product recall
The FDA is pushing for a voluntary recall of certain lots of extended-release metformin after lab tests revealed unacceptable levels of N-nitrosodimethylamine.
READ MORE >

Cardiologist sets sights on improving TAVR outcomes

A new study at the University of Cincinnati aims to find out why some TAVR patients experience clotting issues that can lead to substantial side effects.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Cardiologist sets sights on improving TAVR outcomes

Share on Twitter Share on Facebook Share on Linkedin
A new study at the University of Cincinnati aims to find out why some TAVR patients experience clotting issues that can lead to substantial side effects.
READ MORE >

For high-risk AF patients, NOACs outperform warfarin

Non-vitamin K antagonist oral anticoagulants are a valuable treatment option for atrial fibrillation patients with a prior intracranial hemorrhage, according to new findings published in JAMA Network Open. 

READ MORE >
Blood
Share on Twitter Share on Facebook Share on Linkedin

For high-risk AF patients, NOACs outperform warfarin

Share on Twitter Share on Facebook Share on Linkedin
Blood
Non-vitamin K antagonist oral anticoagulants are a valuable treatment option for atrial fibrillation patients with a prior intracranial hemorrhage, according to new findings published in JAMA Network Open. 
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Key trends in cardiovascular health | FDA approves PFA catheter | Bayer makes a move | Medtech company acquired | CCTA education
CCTA making an impact | Cardiology's biggest trend | Recall confirmed | Philips, Bayer announce new deals | Positron raises $2M
‘Mental clarity’ supplement recalled | New data on SDD after PCI | FDA clears diabetes tech | Stroke on plane leads to lawsuit
FDA approves nasal spray for abnormal heart rhythms | Abbott's big news | CBD shows potential | AI powers new PFA registry
JenaValve acquisition blocked | Cath labs keeping up with changes | A new PAD resource | Supplement recalled | RSNA seeks editor
Week in Review: Trump's heart health | FDA announces multiple recalls | Positron raises $2M | IVL's future | CBD & heart disease
IVL in diabetic patients | CBD shows potential to treat heart disease | Trump regrets heart exam | Big news for MiniMed

Pagination

    • First page « First
    • Previous page ‹‹
    • Page …27
    • Page 28
    • Page 29
    • Page 30
    • Current page 31
    • Page 32
    • Page 33
    • Page 34
    • Page 35 …
    • Next page ››
    • Last page Last »
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme